Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
life sciences
medical devices
national blog main
new york blog main
san diego blog main
san diego top stories
2025
ad-comm
affimed
akcea therapeutics
allogene therapeutics
amicus therapeutics
aphelion capital
approval
apremilast
base editing
bio
biogen
biolinq
biome
blueprint medicineas
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
briefing docs
car-t
celgene
cervical cancer
clinical study
clinical trial
commissioner
continuous glucose monitoring
crispr
crispr therapeutics
cybersecurity
democrats
detection
detroit blog main
What
investors
3
×
million
3
×
glucose
monitoring
new
adds
advance
allogene
approach
approaches
based
bio
biolinq
biosensor
body
breaking
cancer
closed
closes
company
confidence
crispr
diabetes
diversity
free
graphwear
graphwear’s
hot
immunotherapy
including
ipo
juno
juvenile
key
metrics
monitor
nanotech
nearly
needle
patch
Language
unset
Current search:
million
×
investors
×
biotech
×
@techcrunch.com
2 years ago
GraphWear closes $20.5M Series B for a needle-free, nanotech-powered glucose monitor
@xconomy.com
5 years ago
Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
